Thursday, July 20, 2017 2:23:34 PM
•Constitutes a 3rd potential hematologic indication for PLX-R18
https://globenewswire.com/news-release/2016/12/27/901701/0/en/Pluristem-and-New-York-Blood-Center-to-Collaborate-in-Evaluating-PLX-R18-as-an-Adjuvant-Therapy-to-Umbilical-Cord-Blood-Transplantation-Winning-900-000-Funding-From-BIRD.html
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM